Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-006617

MARRONE BIO INNOVATIONS INC · MBII

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 30, 2018
Accepted (ET)
Feb 1, 2018 · 8:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 31, 2018M22,092—A30,092D
Common StockF1Jan 31, 2018M8,630—A38,722D
Common StockF1Jan 31, 2018M36,850—A75,572D
Common StockF1Jan 31, 2018M14,201—A89,773D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F2—Jan 30, 2018A14,201A——Common Stock14,20114,201D
Restricted Stock UnitsF1,F3—Jan 31, 2018M22,092D——Common Stock22,09211,048D
Restricted Stock UnitsF1,F4—Jan 31, 2018M8,630D——Common Stock8,6300D
Restricted Stock UnitsF1,F5—Jan 31, 2018M36,850D——Common Stock36,8500D
Restricted Stock UnitsF1,F2—Jan 31, 2018M14,201D——Common Stock14,2010D

Explanation of responses